Los puntos clave no están disponibles para este artículo en este momento.
Thalidomide is active against advanced myeloma. It can induce marked and durable responses in some patients with multiple myeloma, including those who relapse after high-dose chemotherapy.
Singhal et al. (Thu,) studied this question.